Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 22238217)

1.

Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study.

Castellino SM, Tooze JA, Flowers L, Hill DF, McMullen KP, Shaw EG, Parsons SK.

Pediatr Blood Cancer. 2012 Sep;59(3):540-7. doi: 10.1002/pbc.24078. Epub 2012 Jan 11.

2.

Donepezil improved memory in multiple sclerosis in a randomized clinical trial.

Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE.

Neurology. 2004 Nov 9;63(9):1579-85.

PMID:
15534239
3.

Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life.

Shaw EG, Rosdhal R, D'Agostino RB Jr, Lovato J, Naughton MJ, Robbins ME, Rapp SR.

J Clin Oncol. 2006 Mar 20;24(9):1415-20.

4.

Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.

Leroi I, Brandt J, Reich SG, Lyketsos CG, Grill S, Thompson R, Marsh L.

Int J Geriatr Psychiatry. 2004 Jan;19(1):1-8.

PMID:
14716693
5.

An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients.

Whyte EM, Lenze EJ, Butters M, Skidmore E, Koenig K, Dew MA, Penrod L, Mulsant BH, Pollock BG, Cabacungan L, Reynolds CF 3rd, Munin MC.

Cerebrovasc Dis. 2008;26(3):317-21. doi: 10.1159/000149580. Epub 2008 Jul 31.

6.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
7.

Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures.

Handen BL, Johnson CR, McAuliffe-Bellin S, Murray PJ, Hardan AY.

J Child Adolesc Psychopharmacol. 2011 Feb;21(1):43-50. doi: 10.1089/cap.2010.0024.

8.

Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.

Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R; Donepezil 307 Vascular Dementia Study Group.

Stroke. 2003 Oct;34(10):2323-30. Epub 2003 Sep 11.

9.

Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.

Pelton GH, Harper OL, Tabert MH, Sackeim HA, Scarmeas N, Roose SP, Devanand DP.

Int J Geriatr Psychiatry. 2008 Jul;23(7):670-6.

10.

Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study.

Ashare RL, Ray R, Lerman C, Strasser AA.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):263-7. doi: 10.1016/j.drugalcdep.2012.04.019. Epub 2012 May 15.

11.

Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10-17.

Kishnani PS, Heller JH, Spiridigliozzi GA, Lott I, Escobar L, Richardson S, Zhang R, McRae T.

Am J Med Genet A. 2010 Dec;152A(12):3028-35. doi: 10.1002/ajmg.a.33730.

PMID:
21108390
12.

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study.

Prasher VP, Huxley A, Haque MS; Down syndrome Ageing Study Group.

Int J Geriatr Psychiatry. 2002 Mar;17(3):270-8.

PMID:
11921156
13.

Preliminary study of the safety and efficacy of donepezil hydrochloride in children with Down syndrome: a clinical report series.

Spiridigliozzi GA, Heller JH, Crissman BG, Sullivan-Saarela JA, Eells R, Dawson D, Li J, Kishnani PS.

Am J Med Genet A. 2007 Jul 1;143A(13):1408-13.

PMID:
17542008
14.

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.

Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, Richardson S; Donepezil 401 Study Group.

Neurology. 2004 Aug 24;63(4):651-7.

PMID:
15326237
15.
17.

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease.

Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD; Donepezil Study Group.

Arch Neurol. 2001 Mar;58(3):427-33.

PMID:
11255446
18.

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.

Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM; Donepezil MSAD Study Investigators Group.

Int J Geriatr Psychiatry. 2005 Jun;20(6):559-69.

PMID:
15920715
19.

Effects of donepezil on cognitive functioning in Down syndrome.

Johnson N, Fahey C, Chicoine B, Chong G, Gitelman D.

Am J Ment Retard. 2003 Nov;108(6):367-72.

PMID:
14561111
20.

An open-label trial of donepezil (aricept) in the treatment of persons with mild traumatic brain injury.

Kaye NS, Townsend JB 3rd, Ivins R.

J Neuropsychiatry Clin Neurosci. 2003 Summer;15(3):383-4; author reply 384-5. No abstract available.

PMID:
12928519
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk